Altair Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Altair Therapeutics - overview
Established
2007
Location
San Diego, CA, US
Primary Industry
Pharmaceuticals
About
Altair Therapeutics is a biotechnology company focused on developing innovative therapies for various diseases. It strives to address unmet medical needs through advanced research and development. Altair Therapeutics is a biotechnology firm founded in 2007, located in San Diego, US. The company was established to create therapies targeting unmet medical needs.
Altair Therapeutics has engaged in 3 funding deals and raised a total of USD 17. 00 mn, with the latest funding round being Series B, amounting to USD 17. 00 mn. Notable investors in this round included Domain Associates, Forward Ventures, GeneChem, and Thomas, McNerney & Partners.
Altair Therapeutics specializes in developing therapeutic solutions for various health challenges, focusing on innovative treatment modalities tailored for specific diseases. The company's product portfolio aims to enhance patient outcomes through targeted therapies supported by robust research efforts. Altair Therapeutics generates revenue through its therapeutic products and potential partnerships aimed at advancing pharmaceutical research. Specific financial details regarding pricing and transaction volumes have not been disclosed but are integral to the company’s operational model.
Altair Therapeutics has recently ceased operations and is no longer pursuing future growth initiatives. Therefore, there are no upcoming products or expansion plans to report.
Current Investors
Domain Associates, Forward Ventures, Thomas, McNerney & Partners
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Nanomaterials
Website
www.altairthera.com
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Altair Therapeutics - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.